Dent Neurologic

First Class Research

From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, the DENT Neurosciences Research Center is able to build upon the philosophy by providing advancement, support and education to our providers and partners.

About the DNRC

The Dent Neuroscience Research Center (DNRC) is a 501(c)(3) not-for-profit affiliate of DENT dedicated to outcomes research and education supported by foundations, industry and personal contributions. The DNRC is focused on developing comprehensive, clinically relevant, and cost effective solutions to complex neurological problems faced in our community.

Building awareness, fostering relationships, providing support and continuous education are at the forefront of the DENT philosophy. From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, DNRC is able to build upon the philosophy by providing advancement, support and education to our providers and partners.

Open Studies

Want to participate in a study?

Please call 716-250-2009 and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

  • All
  • Alzheimer's
  • Behavioral Health
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Research Study
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
All
  • All
  • Alzheimer's
  • Behavioral Health
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Research Study
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
Research Study

Sanofi VITALIZE

Sanofi VITALIZE A Phase 3, randomized, double-blind, study evaluating efficacy ...
Read More →
Alzheimer's

BMS TARGET-TAU

BMS TARGET-TAU This study is being done to learn more ...
Read More →
Multiple Sclerosis

TG ENABLE

TG ENABLE The purpose of this study is to evaluate ...
Read More →
Parkisons Disease

EVIDERA EVA-38569-03

EVIDERA EVA-38569-03 This is a cognitive interview study to evaluate ...
Read More →
Research Study

TEVA IMPACT TD

TEVA IMPACT TD Registry (Tardive Dyskinesia) The purpose of this ...
Read More →
Alzheimer's

ALZ-NET

Alzheimer’s National Registry for Treatment and Diagnostics(ALZ-NET) (Mild Cognitive Impairment ...
Read More →
Headache/Migraine

Migraine prevention injection in patients with unsuccessful prior preventive treatments

Migraine prevention injection in patients with unsuccessful prior preventive treatments ...
Read More →
Headache/Migraine

Chronic Migraine Implant for Migraine Prevention (RELIEV-CM2)

Chronic Migraine Implant for Migraine Prevention (RELIEV-CM2) The purpose of ...
Read More →
Headache/Migraine

Menstrual Migraine Prevention

Menstrual Migraine Prevention using Ubrelvy This study will evaluate the ...
Read More →
Multiple Sclerosis

SANOFI EFC17504

SANOFI EFC17504 The purpose of this study is to determine ...
Read More →
Multiple Sclerosis

PIPELINE/CONTINEUM VISTA

PIPELINE/CONTINEUM VISTA This is a randomized, double-blind study of PIPE-307 ...
Read More →
Research Study

INDIVIOR INDV-6000-406

INDIVIOR INDV-6000-406 This study will provide the opportunity to generate ...
Read More →
Active, No Longer Recruiting

Jazz Patagonia

JAZZ PATAGONIA (Parkinson’s Disease) This is a 17-week double-blind, placebo-controlled, ...
Read More →
Alzheimer's

IGC Pharma

IGC PHARMA (Alzheimer’s Disease with Agitation) This is a trial ...
Read More →
Alzheimer's

ACADIA RADIANT

ACADIA RADIANT (Alzheimer’s Disease Psychosis) In this study, researchers will ...
Read More →
Alzheimer's

SUVEN CTP3S1502HT6

SUVEN CTP3S1502HT6 (Alzheimer’s Disease with Agitation) This study will be ...
Read More →
Active, No Longer Recruiting

BIOGEN CELIA

BIOGEN CELIA In this study, researchers will learn more about ...
Read More →
Alzheimer's

ADCS BENFO-TEAM

ADCS BENFO-TEAM The purpose of this study is to learn ...
Read More →
Research Study

OXA1 Study

0XA1 Study This study will test if an investigational medicine ...
Read More →
Uncategorized

CogMS

CogMS – A Real-world Study Into Cognitive Impairment in People ...
Read More →
Research Study

Generation HD-2

Generation HD-2 This study will evaluate the safety, biomarkers, and ...
Read More →

Active Studies, No Longer Recruiting

Sorry, we couldn't find any posts. Please try a different search.

Past Studies

Giving Opportunities

The DNRC is funded through industry grants and clinical trial contracts, foundations, and community donations. Funds support need-based deserving initiatives related to the diagnosis and treatment of neurological disorders in patients from around the Western New York region.

Corporate or individual donors are welcome to designate their contribution to a specific specialty fund or have it applied to the general operating needs where it is most effective. Gifts can be made in many forms, including cash donations, proceeds from community benefits, corporate contributions and matching gifts, grants, planned gifts, gifts of honor or memorials, and more.

Please contact Maria Caserta, mcaserta@dentinstitute.com, to find out more about how you can help support our mission to bring the most comprehensive treatments to our neighbors and their families suffering with neurological disorders.

DNRC Leadership

Michelle Rainka, PharmD, BCPP, CCRP, President

Clinical Pharmacist, Dent Neurologic Institute

Adjunct Instructor in the School of Pharmacy, SUNY at Buffalo

 

Laszlo Mechtler, MD, FAAN, FEAN, FASN, FAHS, Chief Medical Officer – Neurology/Oncology    

Chief Medical Officer, Dent Neurologic Institute

Chief of Neuro-Oncology, Roswell Park Comprehensive Cancer Center

Professor of Neurology, Oncology, & Neurosurgery, SUNY at Buffalo

Numerous other Board and Advisory Board appointments

 

Horacio Capote, MD, LFAPA, FASAM, Chief Medical Officer – Psychiatry

Medical Director of Neuropsychiatry, Dent Neurologic Institute

 

Fran Gengo, PharmD, FCP, Chief Science Officer

Director of Neuropharmacology, Dent Neurologic Institute

Associate Professor of Pharmacy & Neurology, SUNY at Buffalo

Clinical Assistant Professor of Neurosurgery, SUNY at Buffalo

 

Traci Aladeen, PharmD, BCPP, Secretary

Clinical Pharmacist, Dent Neurologic Institute    

Adjunct Instructor in the School of Pharmacy, SUNY at Buffalo

Member, Erie County Department of Mental Health PASSS

 

Chris Ralyea, Jr, MBA, Treasurer             

Chief of Staff, Dent Neurologic Institute

Director of Cannabis Research, Dent Neurologic Institute

Numerous other Board and Advisory Board appointments

 

Anthony Baynes, Director – At Large

Chairman, AJ Baynes Group

Numerous other Board and Advisory Board appointments

 

Chet Gary, DDS, JD, Director – At Large

Clinical Assistant Professor of Restorative Dentistry, University at Buffalo School of Dental Medicine

 

Christine Mann, MBA, Director – At Large

Chief Commercial Officer, Dent Neurologic Institute

Managing Partner, NeuroNet GPO

Managing Director, CareNet

Numerous other Board and Advisory Board appointments

 

Michael Songin, CPA, CVA, CGMA, Director – At Large

Managing Partner, Songin, Luderman, Maciejewski & Meyer CPAs

 

Raul Vazquez, MD, Director – At Large

Chief Executive Officer, GBUCBO

Numerous other Board and Advisory Board appointments

Learn about your disorder

DENT provides the highest quality and compassionate patient care to the Western New York region, the direct result of a tireless commitment to staying on the forefront of medical advances and breakthrough technology.

Research Study Forms

Scroll to Top